Legal & General Group PLC Arcus Biosciences, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

A detailed history of Legal & General Group PLC transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 151,044 shares of RCUS stock, worth $2.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

151,044

Previous 151,044 -0.0%

Holding current value

$2.43 Million

Previous $2.31 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$13.69 - $18.01 $25,422 - $33,444	-1,857 Reduced 1.21%	151,044 $2.31 Million
Q2 2024 Aug 14, 2024	BUY	$14.59 - $18.48 $38,648 - $48,953	2,649 Added 1.76%	152,901 $2.33 Million
Q1 2024 May 14, 2024	BUY	$14.83 - $20.18 $19,605 - $26,677	1,322 Added 0.89%	150,252 $2.84 Million
Q4 2023 Feb 15, 2024	SELL	$13.43 - $19.63 $16,988 - $24,831	-1,265 Reduced 0.84%	148,930 $2.84 Million
Q3 2023 Nov 14, 2023	BUY	$17.62 - $23.54 $90,566 - $120,995	5,140 Added 3.54%	150,195 $2.7 Million
Q2 2023 Aug 14, 2023	SELL	$16.97 - $22.03 $64,231 - $83,383	-3,785 Reduced 2.54%	145,055 $2.95 Million
Q1 2023 May 15, 2023	SELL	$15.96 - $23.15 $27,690 - $40,165	-1,735 Reduced 1.15%	148,840 $2.71 Million
Q4 2022 Feb 14, 2023	BUY	$19.7 - $35.71 $39,872 - $72,277	2,024 Added 1.36%	150,575 $3.11 Million
Q3 2022 Nov 14, 2022	BUY	$23.23 - $30.07 $263,312 - $340,843	11,335 Added 8.26%	148,551 $3.89 Million
Q2 2022 Aug 22, 2022	BUY	$17.23 - $37.73 $1.72 Million - $3.78 Million	100,107 Added 269.76%	137,216 $3.48 Million
Q1 2022 May 16, 2022	BUY	$28.92 - $41.83 $556,044 - $804,265	19,227 Added 107.52%	37,109 $1.17 Million
Q4 2021 Feb 14, 2022	SELL	$31.38 - $48.47 $15,125 - $23,362	-482 Reduced 2.62%	17,882 $723,000
Q3 2021 Nov 15, 2021	BUY	$26.93 - $37.68 $217,998 - $305,019	8,095 Added 78.83%	18,364 $640,000
Q2 2021 Aug 12, 2021	SELL	$22.75 - $35.77 $28,141 - $44,247	-1,237 Reduced 10.75%	10,269 $281,000
Q1 2021 May 17, 2021	BUY	$26.16 - $41.39 $11,641 - $18,418	445 Added 4.02%	11,506 $323,000
Q4 2020 Feb 12, 2021	SELL	$17.0 - $32.36 $1,360 - $2,588	-80 Reduced 0.72%	11,061 $287,000
Q3 2020 Nov 13, 2020	SELL	$17.14 - $25.47 $5,484 - $8,150	-320 Reduced 2.79%	11,141 $191,000
Q2 2020 Aug 14, 2020	BUY	$13.97 - $36.56 $90,469 - $236,762	6,476 Added 129.91%	11,461 $284,000
Q1 2020 May 14, 2020	SELL	$8.78 - $19.28 $14,794 - $32,486	-1,685 Reduced 25.26%	4,985 $69,000
Q3 2019 Nov 13, 2019	BUY	$6.44 - $10.18 $5,486 - $8,673	852 Added 14.64%	6,670 $61,000
Q4 2018 Feb 15, 2019	BUY	$9.74 - $14.5 $42,894 - $63,858	4,404 Added 311.46%	5,818 $62,000
Q3 2018 Nov 20, 2018	BUY	$10.88 - $14.95 $7,082 - $9,732	651 Added 85.32%	1,414 $20,000
Q2 2018 Aug 10, 2018	BUY	$12.24 - $17.05 $9,339 - $13,009	763 New	763 $9,000

Others Institutions Holding RCUS

# of Institutions

201

Shares Held

51.7M

Call Options Held

236K

Put Options Held

141K

View Full List

About Arcus Biosciences, Inc.

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.16B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

More about RCUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Arcus Biosciences, Inc. Transaction History